Joel Martin: TAM is a worldly feature, not a startup success ingredient
Joel Martin · 18 - Bridging Healthcare Innovation and Investment with Joel Martin with HealthX Ventures' Joel Martin · Jan 23, 2025 · at 30:03
Joel Martin of HealthX Ventures shares fundraising advice for early-stage founders pitching venture capitalists.
0:00 / 0:17exact quote · 17.8s
720p mp4 · rendered on demand · StarZero watermark
“Tam is not an ingredient for startup success. That's like a feature of the world. And so I think Focusing too much on the big problems and why this is a great problem to solve or whatever is a bit of a distraction from the real core point of here's a buyer. They want to buy it. Here's how we're going to reach them. And here's how much they're going to pay.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Joel Martin
Joel Martin: Value-based care won't reach 20% of healthcare costs by 2035
“Cause I certainly would not bet on It getting to even 20% of cost being covered by value-based care within the decade, for sure. I think it'll be for sure longer than that.”
Joel Martin: Litigation fears, not patient care, drive healthcare buyer conservatism
“Frankly, to give our first sort of hot take of the conversation, I would say that the, that a lot of the conservatism is driven by Legal and regulatory exposure that there is just a lot of purchasing decisions.”
Joel Martin: Investors overvalue prior healthcare domain experience in startup founders
“I experience in healthcare as unique as healthcare is. At experience in healthcare itself is less critical. It depends on the company, but is less critical than you might think as much as there's a, there is a big learning curve, but there's such a huge learni…”
Joel Martin: Insurance provider directories are often only 50% to 60% accurate
“So the big payers spend millions and millions of dollars on bringing this data into their systems. And they basically get inaccurate data despite spending all that money in a lot of places in the industry, you see maybe 50, 60% accuracy for provider directorie…”
Joel Martin: Founders should resist venture investors' urgency to deploy capital
“I think focusing on those fundamentals that I was talking about and people, people to be patient and not here I'm speaking to founders more probably than investors, but not let the investors sense of urgency. Really affect you that much because that's not the …”